Browse
Explore conditions, clinical trials, and the organisations running them.
Never miss a new study
Get alerted when new trials match your condition
Sign up free to track the conditions you care about and get a personal digest when new trials appear.
By submitting, you agree to our Terms of use
116076 trials found · Page 1192 of 5804
-
New weekly injection shows promise for weight loss in early trial
Disease control OngoingThis study tests how well different doses of the medicine NNC0662-0419 help people living with overweight or obesity. The purpose of the study is to find out if NNC0662-0419 is safe and effective for treating people living with overweight or obesity. There are 2 study treatments …
Phase: PHASE2 • Sponsor: Novo Nordisk A/S • Aim: Disease control
Last updated Jun 27, 2026 12:31 UTC
-
Liver protein TREM-1 may predict steroid response in alcoholic hepatitis
Diagnosis Not yet recruitingBackground \& Rationale Severe alcohol-related hepatitis (SAH) is a serious condition with a 3-month mortality rate of \~30%. Diagnosis and prognosis are complex due to non-specific and insensitive clinical, biological, and histological indicators. Corticosteroids-the only valida…
Sponsor: Central Hospital, Nancy, France • Aim: Diagnosis
Last updated Jun 26, 2026 18:14 UTC
-
New hope for GVHD patients who fail standard therapy?
Disease control Not yet recruitingAn open-label, single-arm clinical trial to evaluate the safety and efficacy of gecacitinib tablets in patients with acute graft-versus-host disease (GVHD) who have failed or are intolerant to ruxolitinib-containing second-line therapy.
Phase: PHASE2 • Sponsor: Ruijin Hospital • Aim: Disease control
Last updated Jun 27, 2026 07:52 UTC
-
Papaya leaf extract tested as dengue treatment for kids
Disease control ENROLLING_BY_INVITATIONThe goal of this clinical trial is to evaluate whether Carica papaya leaf extract (CPLE) can improve platelet counts in children aged 2 to 12 years diagnosed with dengue fever and thrombocytopenia. The main questions it aims to answer are: Does Carica papaya leaf extract signifi…
Phase: PHASE2 • Sponsor: Ziauddin Hospital • Aim: Disease control
Last updated Jun 26, 2026 17:24 UTC
-
Shingles vaccine tested for lung cancer patients: could it boost survival?
Prevention Not yet recruitingTo evaluate the impact of herpes zoster vaccine on the incidence of herpes zoster and survival in lung cancer patients, and to explore its preventive effect and safety.
Sponsor: The First Affiliated Hospital of Guangzhou Medical University • Aim: Prevention
Last updated Jun 26, 2026 16:12 UTC
-
New combo therapy aims to shrink liver tumors before surgery
Disease control TerminatedThis is an early-phase study testing a new combination treatment for cancer. participants will receive a type of radiation therapy called MRI-guided or CT-guided radiotherapy, depending on which imaging method is safe for them. The radiation will be given in three sessions, each …
Phase: PHASE2 • Sponsor: Weill Medical College of Cornell University • Aim: Disease control
Last updated Jun 27, 2026 07:58 UTC
-
Handheld scanners and glucose monitors aim to catch diseases early
Diagnosis ENROLLING_BY_INVITATIONThis study evaluates the effectiveness of Truway Health-sourced portable diagnostic devices, including ultrasound and blood glucose monitors, in early detection of chronic conditions in outpatient primary care settings. Conducted as a prospective interventional trial, 200 partici…
Phase: EARLY_PHASE1 • Sponsor: Truway Health, Inc. • Aim: Diagnosis
Last updated Jun 27, 2026 07:55 UTC
-
New breathing method may protect preemie lungs
Disease control Recruiting nowBronchopulmonary dysplasia (BPD) is a complex disorder and remains the most common complication in very preterm infants. Its incidence is increased with gestational age from 95.5% among infants born at 22 weeks' gestation to 22.2% among those born at 29 weeks' gestation. BPD is a…
Phase: NA • Sponsor: Daping Hospital and the Research Institute of Surgery of the Third Military Medical University • Aim: Disease control
Last updated Jun 27, 2026 07:54 UTC
-
New pill RAP-103 aims to clear psoriasis in 8 weeks
Disease control Recruiting nowRandomized, controlled trial, Proof of Concept, Phase 2 aimed to evaluate the effect of CBP-0276 in dose of 200mg twice dose a day, or placebo administrated for 36 weeks to improve Psoriasis Area and Severity Index (PASI)75 or static Physician's Global Assessment (sPGA) score of …
Phase: PHASE2 • Sponsor: Clarent Biopharma, Inc. • Aim: Disease control
Last updated Jul 02, 2026 00:00 UTC
-
Which drug first? new study aims to optimize breast cancer treatment sequence
Disease control Not yet recruitingThe combination of cyclin-dependent kinase 4/6 inhibitors (CDK4/6i) and endocrine therapy is the standard first-line treatment for advanced HR+ (hormone receptor-positive)/HER2- (human epidermal growth factor receptor 2-negative) breast cancer. However, the optimal treatment stra…
Phase: PHASE4 • Sponsor: Yan Xue • Aim: Disease control
Last updated Jun 26, 2026 14:40 UTC
-
Fewer days of radiation may control brain tumors just as well
Disease control Not yet recruitingThe goal of this prospective, multi-center, randomized double-arm clinical trial is to demonstrate a benefit in term of local control of a shorter spread of hypofractionated stereotactic radiotherapy at D1-2-3 vs D1-3-5, in the treatment of "radioresistant" Brain Metastases (BM).…
Phase: PHASE3 • Sponsor: Centre Paul Strauss • Aim: Disease control
Last updated Jun 26, 2026 16:49 UTC
-
Single gel application may speed healing of diabetic foot wounds
Disease control Not yet recruitingThis multicenter, randomized controlled trial will evaluate the effectiveness and safety of DEBRICHEM®, a topical desiccant gel, when added to standard care for chronic diabetic foot wounds. Chronic diabetic foot ulcers affect up to 25% of people with diabetes and are associated …
Phase: NA • Sponsor: DEBx Medical B.V. • Aim: Disease control
Last updated Jun 27, 2026 07:53 UTC
-
Brain zaps and scans: new hope for alcohol addiction?
Disease control Recruiting nowThe goal of this clinical study is to test the effectiveness of a supplemental fMRI neurofeedback and/or TMS intervention in individuals seeking treatment for Alcohol Use Disorder. After an initial visit, participants will come in once a week for four (4) weeks for an interventi…
Phase: NA • Sponsor: Auburn University • Aim: Disease control
Last updated Jun 27, 2026 07:54 UTC
-
Urine test could personalize TB treatment and save lives
Disease control Recruiting nowIndividual pharmacokinetic variability is an important driver of tuberculosis (TB) treatment failure particularly among undernourished populations, and that suboptimal serum drug concentrations are associated with delayed response to treatment, death, and acquired bacterial drug …
Phase: PHASE1 • Sponsor: University of Virginia • Aim: Disease control
Last updated Jun 27, 2026 09:00 UTC
-
Can a 'Baby Dose' of hormone drugs prevent breast cancer with fewer side effects?
Prevention Recruiting nowThe purpose of the study is to to compare low dose of exemestane (babyexe) versus low dose of tamoxifen (babytam) in terms of change of quality of life from baseline to 12 months.
Phase: PHASE2 • Sponsor: Andrea DeCensi • Aim: Prevention
Last updated Jun 27, 2026 07:57 UTC
-
AI could help doctors spot thyroid problems faster and more accurately
Diagnosis OngoingThe goal of this observational study is to evaluate the diagnostic accuracy and clinical workflow integration of an ultrasound intelligent agent (UIA) for thyroid disease management in a real-world multicenter setting. The primary research question is: Can the UIA improve diagno…
Sponsor: Second Affiliated Hospital of Nanchang University • Aim: Diagnosis
Last updated Jun 27, 2026 08:05 UTC
-
Lung cancer screening gets a Heart-Smart upgrade for heavy smokers
Prevention Recruiting nowIndividuals with extensive smoking history have 2- to 3-fold increased risk of dying prematurely compared to age- and gender-matched peers. Historical data indicate that 55% of heavy smokers will die from cardiovascular disease (CVD), while approximately 5% will die from lung can…
Phase: NA • Sponsor: University Hospital, Akershus • Aim: Prevention
Last updated Jun 27, 2026 08:06 UTC
-
Herbal extract shows promise in calming schizophrenia
Symptom relief CompletedThis study aims to evaluate the effectiveness of Ashwagandha (Withania somnifera) extract as an adjuvant therapy in patients with schizophrenia who are receiving risperidone. Schizophrenia is a chronic mental disorder associated with neuroinflammation and immune dysregulation, in…
Phase: PHASE2 • Sponsor: Hasanuddin University • Aim: Symptom relief
Last updated Jun 27, 2026 12:32 UTC
-
Can a herbal capsule beat cancer fatigue? new trial aims to find out
Symptom relief Recruiting nowThe goal of this clinical trial is to evaluate whether Nuvastatic 300 capsule can reduce cancer-related fatigue in adult patients with colon cancer undergoing first-line chemotherapy. The main questions it aims to answer are: Does Nuvastatic 300 capsule significantly reduce can…
Phase: PHASE3 • Sponsor: Natureceuticals Sdn Bhd • Aim: Symptom relief
Last updated Jun 27, 2026 14:02 UTC
-
Could a softer sedation and early exercise keep ICU patients stronger?
Disease control CompletedThis single-center, prospective, randomized controlled trial aims to evaluate whether an eCASH concept-based analgesia and sedation strategy combined with early goal-directed mobilization can reduce the incidence of intensive care unit-acquired weakness (ICU-AW) in mechanically v…
Phase: NA • Sponsor: The First Affiliated Hospital of Soochow University • Aim: Disease control
Last updated Jul 02, 2026 00:00 UTC